376 results on '"Hoag, Stephen W."'
Search Results
2. Rodent Diets Incorporated with Live Biotherapeutic Products (LBPs): An Innovative Dosing Strategy to Support Preclinical Animal Studies on LBP Intervention
3. Design and Process Considerations for Preparation of Modified Release Ivermectin and Praziquantel Tablets by Wet Granulation
4. Understanding excipient-induced crystallization of spray-dried amorphous solid dispersion
5. ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative
6. Comprehensive evaluation of polymer types and ratios in Spray-Dried Dispersions: Compaction, Dissolution, and physical stability
7. Development and Validation of a Stability-indicating UPLC-DAD Method for the Simultaneous Determination of Ivermectin and Praziquantel in Pharmaceutical Tablets and Dissolution Media
8. Lack of an Effect of Polysorbate 80 on Intestinal Drug Permeability in Humans
9. Impact assessment of the variables affecting the drug release and extraction of polyethylene oxide based tablets
10. Application of near-infrared spectroscopy in detecting residual crystallinity in carbamazepine – Soluplus® solid dispersions prepared with solvent casting and hot-melt extrusion
11. Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersion Tablets
12. Pediatric formulation development – Challenges of today and strategies for tomorrow: Summary report from M−CERSI workshop 2019
13. Evaluation of tableting performance of Poly (ethylene oxide) in abuse-deterrent formulations using compaction simulation studies
14. The effects of spray drying, HPMCAS grade, and compression speed on the compaction properties of itraconazole-HPMCAS spray dried dispersions
15. Elucidating the Variability of Magnesium Stearate and the Correlations With Its Spectroscopic Features
16. Development of Protein–Polymer Conjugate Nanoparticles for Modulation of Dendritic Cell Phenotype and Antigen-Specific CD4 T Cell Responses
17. Lubricant-Sensitivity Assessment of SPRESS® B820 by Near-Infrared Spectroscopy: A Comparison of Multivariate Methods
18. Comparing a Statistical Model and Bayesian Approach to Establish the Design Space for the Coating of Ciprofloxacin HCl Beads at Different Scales of Production
19. In Vitro Assessment of Nasal Insufflation of Comminuted Drug Products Designed as Abuse Deterrent Using the Vertical Diffusion Cell
20. Chapter 2 - Physical States and Thermodynamic Principles in Pharmaceutics
21. Reply to “On the Effect of Common Excipients on the Oral Absorption of Class 3 Drugs”
22. Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir
23. Physical Barrier Type Abuse-Deterrent Formulations: Mechanistic Understanding of Sintering-Induced Microstructural Changes in Polyethylene Oxide Placebo Tablets
24. Utility of Films to Anticipate Effect of Drug Load and Polymer on Dissolution Performance from Tablets of Amorphous Itraconazole Spray-Dried Dispersions
25. Prediction of Dissolution of Sustained Release Coated Ciprofloxacin Beads Using Near-infrared Spectroscopy and Process Parameters: a Data Fusion Approach
26. Decision Support for Excipient Risk Assessment in Pharmaceutical Manufacturing
27. Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder
28. A Multiparticulate Delivery System for Potential Colonic Targeting Using Bovine Serum Albumin as a Model Protein: Theme: Formulation and Manufacturing of Solid Dosage Forms Guest Editors: Tony Zhou and Tonglei Li
29. A Systematic Approach of Employing Quality by Design Principles: Risk Assessment and Design of Experiments to Demonstrate Process Understanding and Identify the Critical Process Parameters for Coating of the Ethylcellulose Pseudolatex Dispersion Using Non-Conventional Fluid Bed Process
30. Delivery of a therapeutic antibody to the lower gastrointestinal tract for the treatment of Clostridium difficile infection (CDI)
31. Quality-by-Design (QbD) for Capsule Formulation and Process Development
32. Advances in Capsule Formulation Development and Technology
33. Quality-by-Design II: Application of Quantitative Risk Analysis to the Formulation of Ciprofloxacin Tablets
34. Advancing Product Quality: a Summary of the Second FDA/PQRI Conference
35. Formulation of smokeless tobacco products with a wide range of pH to study nicotine pharmacokinetics and pharmacodynamics
36. A method for the tribological assessment of oral pharmaceutical liquids
37. Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation
38. Quality-by-Design III: Application of Near-Infrared Spectroscopy to Monitor Roller Compaction In-process and Product Quality Attributes of Immediate Release Tablets
39. Understanding Pharmaceutical Quality by Design
40. Sa2048 DEVELOPMENT AND VALIDATION OF PORCINE ANIMAL MODELS FOR WALLED-OFF PANCREATIC NECROSIS CONTAINING NECROTIC PANCREATIC DEBRIS AND GRANULATION TISSUE WALL
41. Impact Assessment of the Variables Affecting the Drug Release and Extraction of Polyethylene Oxide Based Abuse Deterrent Tablets
42. Spray layering of human immunoglobulin G: Optimization of formulation and process parameters
43. Evaluation of Docosahexaenoic Acid in a Dog Model of Hypertension Induced Left Ventricular Hypertrophy
44. Plasticizer Effects on Physical–Mechanical Properties of Solvent Cast Soluplus® Films
45. Quality by Design I: Application of Failure Mode Effect Analysis (FMEA) and Plackett–Burman Design of Experiments in the Identification of “Main Factors” in the Formulation and Process Design Space for Roller-Compacted Ciprofloxacin Hydrochloride Immediate-Release Tablets
46. Quality-by-Design (QbD): Effects of Testing Parameters and Formulation Variables on the Segregation Tendency of Pharmaceutical Powder Measured by the ASTM D 6940-04 Segregation Tester
47. Quality by Design, Part I: Application of NIR Spectroscopy to Monitor Tablet Manufacturing Process
48. Quality by Design, Part II: Application of NIR Spectroscopy to Monitor the Coating Process for a Pharmaceutical Sustained Release Product
49. Quality by Design, Part III: Study of Curing Process of Sustained Release Coated Products using NIR Spectroscopy
50. Effect of Grewia Gum as a Suspending Agent on Ibuprofen Pediatric Formulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.